东宝生物 - Financials

东宝生物 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008
+Revenue	885.0M	975.0M	943.0M	612.0M	449.0M	492.0M	453.0M	356.0M	317.0M	292.0M	251.0M	382.0M	256.0M	208.0M	192.0M	155.0M	119.0M
Revenue Growth %	-9.2%	3.4%	54.1%	36.3%	-8.7%	8.6%	27.2%	12.3%	8.6%	16.3%	-34.3%	49.2%	23.1%	8.3%	23.9%	30.3%	--
Total Revenue	885.0M	975.0M	943.0M	612.0M	449.0M	492.0M	453.0M	356.0M	317.0M	292.0M	251.0M	382.0M	256.0M	208.0M	192.0M	155.0M	119.0M
Cost Of Revenue	684.0M	726.0M	710.0M	516.0M	379.0M	398.0M	353.0M	280.0M	252.0M	236.0M	204.0M	287.0M	171.0M	154.0M	146.0M	126.0M	93.1M
+Gross Profit	201.0M	249.0M	233.0M	96.0M	70.0M	94.0M	100.0M	76.0M	65.0M	56.0M	47.0M	95.0M	85.0M	54.0M	46.0M	29.0M	25.9M
Gross Margin %	22.7%	25.5%	24.7%	15.7%	15.6%	19.1%	22.1%	21.3%	20.5%	19.2%	18.7%	24.9%	33.2%	26.0%	24.0%	18.7%	21.8%
Total Operating Cost	787.0M	837.0M	821.0M	579.0M	436.0M	464.0M	418.0M	334.0M	302.0M	289.0M	247.0M	339.0M	213.0M	182.0M	168.0M	143.0M	111.0M
Selling Expenses	18.7M	19.6M	17.8M	10.3M	9.2M	19.7M	19.4M	17.3M	19.9M	19.1M	14.5M	18.0M	18.3M	11.6M	5.3M	3.9M	3.3M
Admin Expenses	50.0M	51.5M	51.2M	29.9M	26.1M	27.2M	25.0M	23.0M	27.4M	22.5M	20.8M	21.7M	19.6M	12.5M	10.7M	7.5M	8.9M
Rd Expenses	27.4M	26.1M	25.8M	13.0M	9.9M	11.3M	9.9M	6.0M	--	--	--	--	--	--	--	--	--
Finance Expenses	-5.4M	-1.3M	2.2M	2.0M	5.5M	108,500	2.6M	313,400	-611,000	7.4M	7.6M	8.4M	3.2M	3.0M	5.1M	4.8M	5.0M
+Operating Income	106.0M	144.0M	131.0M	41.7M	19.8M	36.2M	39.2M	26.5M	17.9M	3.7M	3.7M	43.2M	42.4M	25.2M	24.3M	12.2M	8.2M
Operating Margin %	12.0%	14.8%	13.9%	6.8%	4.4%	7.4%	8.7%	7.4%	5.7%	1.3%	1.5%	11.3%	16.6%	12.1%	12.6%	7.9%	6.9%
Non Operating Income	341,800	1.6M	1.7M	494,700	38,200	147,500	6,400	72,300	7.1M	3.8M	2.8M	8.6M	2.1M	4.0M	1.4M	1.5M	3.3M
Non Operating Expenses	890,400	1.0M	555,300	647,600	130,300	154,400	35,400	90,000	2.3M	180,000	1,800	563,200	2.7M	87,500	96,300	182,700	199,800
Investment Income	-3.7M	-4.3M	-1.9M	-2.5M	-1.4M	-634,300	-773.64	1.3M	3.1M	526,500	--	--	--	--	--	--	--
Asset Disposal Income	-284,100	76,700	136,600	93,200	6,800	1.6M	15,400	-62,800	-29,800	--	--	--	--	--	--	--	--
Asset Impairment Loss	3.3M	1.4M	1.1M	-172,100	471,900	--	2.0M	2.9M	163,900	1.4M	-187,600	2.0M	-108,900	219,900	62,500	269,100	145,700
Other Income	12.4M	10.9M	10.1M	11.2M	8.0M	6.9M	4.2M	2.7M	--	--	--	--	--	--	--	--	--
Income Before Tax	106.0M	144.0M	132.0M	41.5M	19.7M	36.2M	39.2M	26.4M	22.8M	7.4M	6.5M	51.2M	41.8M	29.1M	25.6M	13.5M	11.4M
Income Tax	14.4M	17.1M	16.2M	5.7M	1.5M	3.6M	5.2M	4.0M	3.6M	1.5M	1.6M	8.6M	6.5M	4.4M	4.0M	2.2M	-512,300
+Net Income	91.3M	127.0M	115.0M	35.8M	18.2M	32.6M	34.0M	22.4M	19.2M	5.9M	4.9M	42.6M	35.4M	24.7M	21.6M	11.4M	11.9M
Net Margin %	10.3%	13.0%	12.2%	5.9%	4.1%	6.6%	7.5%	6.3%	6.1%	2.0%	1.9%	11.2%	13.8%	11.9%	11.3%	7.3%	10.0%
Net Income Attributable	86.0M	120.0M	109.0M	36.5M	18.5M	32.9M	34.0M	22.4M	19.2M	5.9M	4.9M	42.6M	35.4M	24.7M	21.6M	11.4M	11.9M
Minority Interest	5.3M	7.5M	6.0M	-661,400	-256,000	-313,800	--	--	--	--	--	--	--	--	--	--	--
Eps Basic	0.14	0.20	0.18	0.06	0.04	0.06	0.07	0.05	0.04	0.01	0.02	0.22	0.18	0.19	0.38	0.20	0.21
Eps Diluted	0.13	0.20	0.18	0.06	0.04	0.06	0.07	0.05	0.04	0.01	0.02	0.22	0.18	0.19	0.38	0.20	0.21

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008
Cash And Equivalents	532.0M	749.0M	356.0M	226.0M	48.0M	66.3M	98.4M	54.4M	142.0M	255.0M	50.3M	91.7M	122.0M	114.0M	8.3M	6.6M	5.1M
Accounts Receivable	206.0M	162.0M	146.0M	150.0M	95.5M	102.0M	97.5M	68.9M	44.4M	53.3M	39.1M	48.9M	8.4M	10.3M	9.7M	7.2M	6.4M
Notes Receivable	71.2M	89.5M	123.0M	101.0M	--	--	38.1M	25.4M	37.4M	26.1M	42.2M	28.2M	27.2M	22.1M	18.1M	3.3M	3.0M
Notes And Accounts Receivable	277.0M	252.0M	269.0M	251.0M	95.5M	102.0M	136.0M	94.3M	81.8M	79.4M	81.3M	77.1M	35.7M	32.4M	27.8M	10.5M	9.4M
Prepayments	9.4M	7.7M	10.5M	11.5M	8.5M	6.2M	5.7M	4.7M	2.8M	10.5M	9.3M	8.6M	14.5M	10.6M	2.5M	1.0M	11.5M
Inventory	354.0M	282.0M	318.0M	346.0M	287.0M	232.0M	229.0M	155.0M	97.1M	127.0M	158.0M	113.0M	92.3M	47.0M	51.0M	59.9M	55.1M
Total Current Assets	1.2B	1.4B	1.0B	893.0M	483.0M	474.0M	477.0M	313.0M	328.0M	473.0M	302.0M	292.0M	266.0M	205.0M	93.2M	79.9M	84.0M
Long Term Equity Investment	15.4M	18.8M	22.7M	29.3M	25.2M	21.2M	6.9M	4.0M	2.3M	--	--	--	--	--	--	--	--
Fixed Assets	--	798.0M	859.0M	873.0M	738.0M	620.0M	471.0M	492.0M	185.0M	200.0M	207.0M	205.0M	200.0M	109.0M	115.0M	120.0M	96.6M
Fixed Assets Total	999.0M	798.0M	859.0M	873.0M	738.0M	620.0M	471.0M	492.0M	185.0M	200.0M	207.0M	205.0M	200.0M	109.0M	115.0M	120.0M	96.6M
Construction In Progress	--	365.0M	160.0M	94.1M	73.8M	123.0M	166.0M	82.4M	237.0M	33.0M	1.7M	9.1M	9.8M	54.2M	2.9M	496,400	12.9M
Construction In Progress Total	205.0M	365.0M	160.0M	94.1M	73.8M	123.0M	166.0M	82.4M	237.0M	33.0M	1.7M	9.1M	9.8M	54.7M	2.9M	496,400	12.9M
Intangible Assets	143.0M	145.0M	152.0M	175.0M	78.1M	64.4M	65.4M	71.7M	72.0M	59.2M	7.1M	7.7M	7.4M	7.9M	8.2M	5.8M	6.0M
Long Term Deferred Expenses	2.9M	3.2M	2.6M	1.7M	--	--	--	175,400	175,400	392,700	1.3M	2.4M	--	--	--	--	--
Total Non Current Assets	1.4B	1.4B	1.3B	1.2B	935.0M	841.0M	722.0M	659.0M	505.0M	307.0M	228.0M	228.0M	220.0M	172.0M	127.0M	127.0M	116.0M
Total Assets	2.6B	2.7B	2.3B	2.1B	1.4B	1.3B	1.2B	972.0M	833.0M	780.0M	531.0M	520.0M	485.0M	378.0M	220.0M	207.0M	200.0M
Short Term Borrowings	--	5.8M	2.1M	50.5M	90.9M	11.0M	40.0M	--	--	--	--	--	--	44.0M	54.8M	55.0M	46.0M
Accounts Payable	133.0M	126.0M	95.2M	91.4M	156.0M	144.0M	208.0M	173.0M	75.4M	34.7M	51.0M	32.7M	18.0M	14.1M	14.6M	27.9M	29.2M
Advance Receipts	--	--	--	--	--	12.0M	4.0M	4.4M	4.7M	3.3M	1.4M	984,900	10.2M	529,500	49,800	202,600	51,300
Contract Liabilities	9.9M	7.0M	14.3M	4.8M	10.8M	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	324.0M	301.0M	316.0M	421.0M	350.0M	246.0M	362.0M	192.0M	86.0M	53.3M	170.0M	42.0M	37.0M	63.5M	78.6M	91.7M	88.1M
Long Term Borrowings	36.0M	44.8M	152.0M	--	8.0M	27.0M	15.5M	24.0M	--	--	--	--	--	--	--	--	--
Total Non Current Liabilities	562.0M	548.0M	236.0M	87.2M	70.1M	79.2M	86.3M	50.0M	28.3M	20.2M	20.5M	126.0M	124.0M	18.2M	19.0M	14.9M	14.1M
Total Liabilities	885.0M	849.0M	552.0M	509.0M	420.0M	325.0M	448.0M	242.0M	114.0M	73.5M	190.0M	168.0M	161.0M	81.6M	97.6M	107.0M	102.0M
Paid In Capital	594.0M	594.0M	594.0M	594.0M	522.0M	523.0M	464.0M	461.0M	461.0M	230.0M	198.0M	198.0M	152.0M	76.0M	57.0M	57.0M	57.0M
Capital Reserve	644.0M	636.0M	636.0M	636.0M	314.0M	318.0M	159.0M	152.0M	152.0M	383.0M	51.5M	51.5M	66.7M	142.0M	12.6M	12.4M	11.9M
Surplus Reserve	65.0M	58.7M	47.6M	37.1M	33.1M	31.6M	28.6M	25.6M	23.4M	21.4M	20.5M	19.5M	14.7M	11.1M	8.7M	6.5M	5.4M
Retained Earnings	411.0M	345.0M	252.0M	156.0M	124.0M	122.0M	108.0M	91.0M	82.4M	72.0M	71.0M	82.8M	90.7M	66.4M	44.2M	24.7M	23.6M
Minority Equity	-119,400	235.0M	227.0M	181.0M	8.2M	486,200	--	--	--	--	--	--	--	--	--	--	--
Equity Attributable	1.7B	1.7B	1.5B	1.4B	990.0M	989.0M	751.0M	730.0M	719.0M	707.0M	341.0M	351.0M	324.0M	296.0M	122.0M	101.0M	97.9M
Total Equity	1.7B	1.9B	1.8B	1.6B	998.0M	990.0M	751.0M	730.0M	719.0M	707.0M	341.0M	351.0M	324.0M	296.0M	122.0M	101.0M	97.9M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008
Cash From Sales	595.0M	683.0M	652.0M	367.0M	332.0M	273.0M	261.0M	169.0M	178.0M	153.0M	136.0M	307.0M	245.0M	139.0M	203.0M	177.0M	99.9M
Tax Refunds Received	11.5M	9.7M	5.1M	4.9M	--	--	--	--	--	--	--	--	--	--	--	--	--
Total Operating Cash Inflow	629.0M	712.0M	689.0M	386.0M	350.0M	280.0M	294.0M	170.0M	193.0M	168.0M	141.0M	317.0M	249.0M	142.0M	204.0M	180.0M	109.0M
Cash Paid For Goods	326.0M	248.0M	243.0M	204.0M	208.0M	220.0M	143.0M	102.0M	56.1M	54.3M	92.8M	230.0M	181.0M	66.1M	149.0M	138.0M	90.5M
Cash Paid To Employees	158.0M	150.0M	152.0M	71.6M	55.0M	56.2M	53.2M	42.4M	33.6M	32.8M	29.6M	30.9M	24.4M	17.5M	13.6M	10.6M	8.7M
Taxes Paid	51.2M	89.7M	73.2M	39.8M	15.3M	25.2M	16.1M	10.2M	18.2M	23.9M	11.4M	32.5M	19.3M	19.8M	17.9M	9.7M	5.7M
Total Operating Cash Outflow	560.0M	512.0M	494.0M	335.0M	287.0M	322.0M	234.0M	174.0M	153.0M	123.0M	153.0M	308.0M	244.0M	118.0M	192.0M	166.0M	114.0M
Operating Cash Flow	69.1M	199.0M	195.0M	51.5M	63.1M	-41.6M	60.0M	-3.1M	40.5M	45.6M	-12.2M	9.1M	5.5M	24.2M	11.9M	13.8M	-4.2M
Total Investing Cash Inflow	2.3B	305.0M	196.0M	216.0M	27,500	79,500	--	259.0M	1.2B	201.0M	--	244,300	23,500	46,100	--	899,000	--
Total Investing Cash Outflow	2.6B	435.0M	420.0M	384.0M	159.0M	140.0M	58.2M	363.0M	1.3B	284.0M	13.9M	23.8M	53.7M	52.1M	9.7M	9.7M	3.9M
Investing Cash Flow	-266.0M	-130.0M	-224.0M	-168.0M	-159.0M	-140.0M	-58.2M	-104.0M	-158.0M	-83.9M	-13.9M	-23.5M	-53.7M	-52.0M	-9.7M	-8.8M	-3.9M
Cash From Borrowings	3.0M	447.0M	210.0M	84.8M	148.0M	79.0M	40.0M	28.0M	--	110.0M	--	--	149.0M	48.8M	131.0M	119.0M	62.2M
Dividends And Interest Paid	15.8M	21.3M	11.2M	5.7M	20.6M	19.5M	12.8M	7.4M	4.3M	14.6M	17.3M	17.1M	5.7M	6.7M	5.3M	9.2M	4.9M
Debt Repayments	8.0M	148.0M	67.1M	210.0M	41.5M	75.0M	7.7M	800,000	--	220.0M	--	--	83.0M	59.5M	131.0M	114.0M	51.0M
Total Financing Cash Inflow	5.4M	477.0M	253.0M	489.0M	155.0M	302.0M	58.5M	28.0M	9.5M	478.0M	2.0M	2.0M	149.0M	205.0M	137.0M	120.0M	64.6M
Total Financing Cash Outflow	23.8M	172.0M	78.3M	228.0M	65.7M	134.0M	47.3M	8.7M	4.3M	235.0M	17.3M	17.6M	92.6M	72.1M	137.0M	124.0M	56.3M
Financing Cash Flow	-18.4M	306.0M	175.0M	261.0M	89.6M	169.0M	11.1M	19.3M	5.2M	243.0M	-15.3M	-15.6M	56.4M	133.0M	-512,700	-3.5M	8.4M
Net Change In Cash	-215.0M	375.0M	147.0M	144.0M	-6.2M	-13.1M	13.0M	-88.0M	-113.0M	205.0M	-41.4M	-30.1M	8.2M	105.0M	1.7M	1.5M	303,700
Ending Cash Balance	498.0M	713.0M	338.0M	192.0M	47.8M	54.0M	67.1M	54.2M	142.0M	255.0M	50.3M	91.7M	122.0M	114.0M	8.3M	6.6M	5.1M
Capex	77.2M	132.0M	109.0M	51.4M	152.0M	130.0M	55.2M	104.0M	158.0M	84.4M	13.9M	23.8M	53.7M	52.1M	9.7M	9.7M	3.9M